Technische Universität Hamburg-Harburg, Bioprozeß- und Bioverfahrenstechnik, Denickestr. 15, 21071, Hamburg, Germany.
Cytotechnology. 1997 Jan;23(1-3):39-45. doi: 10.1023/A:1007911517505.
An industrial scale reactor concept for continuous cultivation of immobilized animal cells (e.g. hybridoma cells) in a radial-flow fixed bed is presented, where low molecular weight metabolites are removed via dialysis membrane and high molecular products (e.g. monoclonal antibodies) are enriched. In a new "nutrient-split" feeding strategy concentrated medium is fed directly to the fixed bed unit, whereas a buffer solution is used as dialysis fluid. This feeding strategy was investigated in a laboratory scale reactor with hybridoma cells for production of monoclonal antibodies. A steady state monoclonal antibody concentration of 478 mg l(-1) was reached, appr. 15 times more compared to the concentration reached in chemostat cultures with suspended cells. Glucose and glutamine were used up to 98%. The experiments were described successfully with a kinetic model for immobilized growing cells. Conclusions were drawn for scale-up and design of the large scale system.
c(Glc) - glucose concentration, mmol l(-1); c(Gln) - glutamine concentration, mmol l(-1); c(Amm) - ammonia concentration, mmol l(-1); c(Lac) - lactate concentration, mmol l(-1); c(MAb) - MAb concentration, mg l(-1); D - dilution rate, d(-1); D(i) - dilution rate in the inner chamber of the membrane dialysis reactor, d(-1); D(0) - dilution rate in the outer chamber of the membrane dialysis reactor, d(-1); q*(FB,Glc) - volume specific glucose uptake rate related to the fixed bed volume, mmol l(FB) (-1) h(-1); q*(FB,Gln) - volume specific glutamine uptake rate related to the fixed bed volume, mmol l(FB) (-1) h(-1).
介绍了一种用于在径向流固定床中连续培养固定化动物细胞(例如杂交瘤细胞)的工业规模反应器概念,其中通过透析膜去除低分子量代谢物,并浓缩高分子产物(例如单克隆抗体)。在一种新的“养分分裂”给料策略中,浓缩培养基直接进料到固定床单元,而缓冲液用作透析液。该给料策略已在使用杂交瘤细胞生产单克隆抗体的实验室规模反应器中进行了研究。达到了 478mg l(-1)的稳定单克隆抗体浓度,与悬浮细胞恒化培养达到的浓度相比,提高了约 15 倍。葡萄糖和谷氨酰胺的利用率达到 98%。使用固定化生长细胞的动力学模型成功地描述了实验。得出了放大和设计大型系统的结论。
c(Glc)-葡萄糖浓度,mmol l(-1);c(Gln)-谷氨酰胺浓度,mmol l(-1);c(Amm)-氨浓度,mmol l(-1);c(Lac)-乳酸浓度,mmol l(-1);c(MAb)-MAb 浓度,mg l(-1);D-稀释率,d(-1);D(i)-膜透析反应器内室的稀释率,d(-1);D(0)-膜透析反应器外室的稀释率,d(-1);q*(FB,Glc)-与固定床体积相关的体积特异性葡萄糖摄取率,mmol l(FB) (-1) h(-1);q*(FB,Gln)-与固定床体积相关的体积特异性谷氨酰胺摄取率,mmol l(FB) (-1) h(-1)。